China Medical tests the health of HY demand
China Medical Technologies is planning to issue a $175m five year non-call three bond, after finishing a roadshow in Asia, Europe and the US, by the middle of next week — offering investors a rare chance to buy a single-B rated mainland credit outside of the market-dominating property sector.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts